PSA

(redirected from prostate specific antigen)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to prostate specific antigen: Prostate Enlargement

PSA

Security Industry and Financial Markets Association

Formerly known as the Public Securities Association, a professional organization for banks, broker-dealers, and other organizations that underwrite securities. It serves as a lobbying group and provides education and training to members and non-members. It maintains offices in New York, Washington DC, and London, with affiliated offices in Hong Kong and other locations.
References in periodicals archive ?
Effects of gonadotropin and testosterone treatments on prostate volume and serum prostate specific antigen levels in male hypogonadism.
Age, prostate specific antigen (PSA) levels, and prostate volume in benign prostate hyperplasia (BPH) patients with and without chronic prostatitis (mean[+ or -]SD) BPH BPH+chronic Total P (n=92) prostatitis (n=214) value (a) (n=60) Age (year) 62.
Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease.
Prostate cancer detection at low prostate specific antigen, J Urol.
Tom Stamey at Stanford University Medical Center, a world-renowned expert on prostate cancer, and a Member of the HDC Science Team "The Era of PSA is over" because of the low accuracy rate of Prostate Specific Antigen in identifying clinically significant prostate cancer.
Primary reference preparations used to standardize calibration of immunochemical assays for serum prostate specific antigen (PSA); approved guideline.
Of the 13 patients that were evaluable for antitumor activity, 9 patients (69%) experienced a confirmed decline in prostate specific antigen (PSA) levels of greater than 50% and 6 patients (46%) experienced PSA declines of greater than 90%.
Contract awarded for code total 12644 prostate specific antigen, reagent for the determination test
Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.
Of the 12 patients that were evaluable for antitumor activity, 8 patients (67%) experienced a confirmed decline in prostate specific antigen (PSA) levels of greater than 50% and 6 patients (50%) experienced PSA declines of greater than 90%.
Contract awarded for code 12643 free prostate specific antigen, reagent for the determination test
Clinical use of prostate specific antigen in patients with prostate cancer.
Full browser ?